145 related articles for article (PubMed ID: 36326317)
21. Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System.
Travaglino A; Raffone A; Saccone G; Mascolo M; Guida M; Mollo A; Insabato L; Zullo F
Am J Clin Pathol; 2020 Jan; 153(1):40-48. PubMed ID: 31433834
[TBL] [Abstract][Full Text] [Related]
22. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.
Mutter GL; Zaino RJ; Baak JP; Bentley RC; Robboy SJ
Int J Gynecol Pathol; 2007 Apr; 26(2):103-14. PubMed ID: 17413975
[TBL] [Abstract][Full Text] [Related]
23. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
[No Abstract] [Full Text] [Related]
25. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
26. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
Trabzonlu L; Muezzinoglu B; Corakci A
Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
[TBL] [Abstract][Full Text] [Related]
27. Hysterectomy with a general gynecologist vs gynecologic-oncologist in the setting of endometrial intraepithelial neoplasia: a cost-effectiveness analysis.
Chaiken SR; Bohn JA; Bruegl AS; Caughey AB; Munro EG
Am J Obstet Gynecol; 2022 Oct; 227(4):609.e1-609.e8. PubMed ID: 35662547
[TBL] [Abstract][Full Text] [Related]
28. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
[TBL] [Abstract][Full Text] [Related]
29. International Internet-based assessment of observer variability for diagnostically challenging endometrial biopsies.
Marotti JD; Glatz K; Parkash V; Hecht JL
Arch Pathol Lab Med; 2011 Apr; 135(4):464-70. PubMed ID: 21466363
[TBL] [Abstract][Full Text] [Related]
30. YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia.
Bian PP; Liu SY; Luo QP; Xiong ZT
Pathol Res Pract; 2022 Jun; 234():153919. PubMed ID: 35512522
[TBL] [Abstract][Full Text] [Related]
31. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
[TBL] [Abstract][Full Text] [Related]
33. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.
Kalogiannidis I; Agorastos T
J Obstet Gynaecol; 2011; 31(1):13-7. PubMed ID: 21280986
[TBL] [Abstract][Full Text] [Related]
34. Endometrial intraepithelial neoplasia terminology in practice: 4-year experience at a single institution.
Kane SE; Hecht JL
Int J Gynecol Pathol; 2012 Mar; 31(2):160-165. PubMed ID: 22317874
[TBL] [Abstract][Full Text] [Related]
35. Endometrial intraepithelial neoplasia: clinical correlates and outcomes.
Semere LG; Ko E; Johnson NR; Vitonis AF; Phang LJ; Cramer DW; Mutter GL
Obstet Gynecol; 2011 Jul; 118(1):21-28. PubMed ID: 21691159
[TBL] [Abstract][Full Text] [Related]
36. Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience.
Wang Y; Yu M; Yang JX; Cao DY; Yuan Z; Zhou HM; Zhang Y; Li L; Shen K; Wu H
Int J Clin Oncol; 2019 Jun; 24(6):712-720. PubMed ID: 30746595
[TBL] [Abstract][Full Text] [Related]
37. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
[TBL] [Abstract][Full Text] [Related]
38. Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia.
Ørbo A; Moe BT; Arnes M; Pettersen I; Larsen K; Eggen T; Myrmel K; Hanssen K
Anticancer Res; 2010 Nov; 30(11):4649-55. PubMed ID: 21115919
[TBL] [Abstract][Full Text] [Related]
39. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
40. Secretory endometrial intraepithelial neoplasia.
Jeffus SK; Winham W; Hooper K; Quick CM
Int J Gynecol Pathol; 2014 Sep; 33(5):515-6. PubMed ID: 25083969
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
